13 Females of childbearing potential must not participate in a conception process ie active attempt to become pregnant or to impregnate in vitro fertilization and must not have had unprotected sexual intercourse within 30 days before study entry and must agree to use a highly effective method of contraception eg total abstinence an intrauterine device a double-barrier method such as condom plus diaphragm with spermicide a contraceptive implant an oral contraceptive or have a vasectomized partner with confirmed azoospermia for at least 4 weeks before dosing throughout the entire study period and for 4 weeks after study drug discontinuation If currently abstinent the subject must agree to use a double-barrier method as described above if she becomes sexually active during the study period or for 4 weeks after study drug discontinuation Females who are using hormonal contraceptives must have been on a stable dose of the same hormonal contraceptive product for at least 4 weeks before dosing and must continue to use the same contraceptive during the study and for 4 weeks after study drug discontinuation 